Literature DB >> 27859650

Profile of cognitive impairment and underlying pathology in multiple system atrophy.

Shunsuke Koga1, Adam Parks2, Ryan J Uitti3, Jay A van Gerpen3, William P Cheshire3, Zbigniew K Wszolek3, Dennis W Dickson1.   

Abstract

BACKGROUND: The objectives of this study were to elucidate any potential association between α-synuclein pathology and cognitive impairment and to determine the profile of cognitive impairment in multiple system atrophy (MSA) patients. To do this, we analyzed the clinical and pathologic features in autopsy-confirmed MSA patients.
METHODS: We retrospectively reviewed medical records, including neuropsychological test data, in 102 patients with autopsy-confirmed MSA in the Mayo Clinic brain bank. The burden of glial cytoplasmic inclusions and neuronal cytoplasmic inclusions were semiquantitatively scored in the limbic regions and middle frontal gyrus. We also assessed concurrent pathologies potentially causing dementia including Alzheimer's disease, hippocampal sclerosis, and cerebrovascular pathology.
RESULTS: Of 102 patients, 33 (32%) were documented to have cognitive impairment. Those that received objective testing, deficits primarily in processing speed and attention/executive functions were identified, which suggests a frontal-subcortical pattern of dysfunction. Of these 33 patients with cognitive impairment, 8 patients had concurrent pathologies of dementia. MSA patients with cognitive impairment had a greater burden of neuronal cytoplasmic inclusions in the dentate gyrus than patients without cognitive impairment, both including and excluding patients with concurrent pathologies of dementia.
CONCLUSIONS: The cognitive deficits observed in this study were more evident on neuropsychological assessment than with cognitive screens. Based on these findings, we recommend that clinicians consider more in-depth neuropsychological assessments if patients with MSA present with cognitive complaints. Although we did not identify the correlation between cognitive deficits and responsible neuroanatomical regions, a greater burden of neuronal cytoplasmic inclusions in the limbic regions was associated with cognitive impairment in MSA.
© 2016 International Parkinson and Movement Disorder Society. © 2016 International Parkinson and Movement Disorder Society.

Entities:  

Keywords:  Alzheimer type pathology; cognitive impairment; multiple system atrophy; neuronal cytoplasmic inclusion; α-synuclein pathology

Mesh:

Substances:

Year:  2016        PMID: 27859650      PMCID: PMC5359072          DOI: 10.1002/mds.26874

Source DB:  PubMed          Journal:  Mov Disord        ISSN: 0885-3185            Impact factor:   10.338


  38 in total

1.  Proposed neuropathological criteria for the post mortem diagnosis of multiple system atrophy.

Authors:  J Q Trojanowski; T Revesz
Journal:  Neuropathol Appl Neurobiol       Date:  2007-12       Impact factor: 8.090

2.  Neuropathological features of multiple system atrophy with cognitive impairment.

Authors:  Y T Asi; Helen Ling; Z Ahmed; A J Lees; T Revesz; J L Holton
Journal:  Mov Disord       Date:  2014-04-18       Impact factor: 10.338

3.  A short test of mental status: description and preliminary results.

Authors:  E Kokmen; J M Naessens; K P Offord
Journal:  Mayo Clin Proc       Date:  1987-04       Impact factor: 7.616

4.  Atypical multiple system atrophy is a new subtype of frontotemporal lobar degeneration: frontotemporal lobar degeneration associated with α-synuclein.

Authors:  Naoya Aoki; Philip J Boyer; Cheryl Lund; Wen-Lang Lin; Shunsuke Koga; Owen A Ross; Myron Weiner; Anne Lipton; James M Powers; Charles L White; Dennis W Dickson
Journal:  Acta Neuropathol       Date:  2015-05-12       Impact factor: 17.088

5.  Executive dysfunction in mild cognitive impairment is associated with changes in frontal and cingulate white matter tracts.

Authors:  Ramune Grambaite; Per Selnes; Ivar Reinvang; Dag Aarsland; Erik Hessen; Leif Gjerstad; Tormod Fladby
Journal:  J Alzheimers Dis       Date:  2011       Impact factor: 4.472

6.  Glial cytoplasmic inclusions in the CNS of patients with multiple system atrophy (striatonigral degeneration, olivopontocerebellar atrophy and Shy-Drager syndrome).

Authors:  M I Papp; J E Kahn; P L Lantos
Journal:  J Neurol Sci       Date:  1989-12       Impact factor: 3.181

7.  Frequent globular neuronal cytoplasmic inclusions in the medial temporal region as a possible characteristic feature in multiple system atrophy with dementia.

Authors:  Taku Homma; Yoko Mochizuki; Takashi Komori; Eiji Isozaki
Journal:  Neuropathology       Date:  2016-03-11       Impact factor: 1.906

8.  A cross-sectional multicenter study of cognitive and behavioural features in multiple system atrophy patients of the parkinsonian and cerebellar type.

Authors:  C Siri; S Duerr; M Canesi; M Delazer; R Esselink; B R Bloem; T Gurevich; M Balas; N Giladi; P Santacruz; F Marti; E Tolosa; A Rubino; G Meco; W Poewe; G Pezzoli; G Wenning; A Antonini
Journal:  J Neural Transm (Vienna)       Date:  2013-03-06       Impact factor: 3.575

9.  Second consensus statement on the diagnosis of multiple system atrophy.

Authors:  S Gilman; G K Wenning; P A Low; D J Brooks; C J Mathias; J Q Trojanowski; N W Wood; C Colosimo; A Dürr; C J Fowler; H Kaufmann; T Klockgether; A Lees; W Poewe; N Quinn; T Revesz; D Robertson; P Sandroni; K Seppi; M Vidailhet
Journal:  Neurology       Date:  2008-08-26       Impact factor: 9.910

10.  The spectrum of pathological involvement of the striatonigral and olivopontocerebellar systems in multiple system atrophy: clinicopathological correlations.

Authors:  Tetsutaro Ozawa; Dominic Paviour; Niall P Quinn; Keith A Josephs; Hardev Sangha; Linda Kilford; Daniel G Healy; Nick W Wood; Andrew J Lees; Janice L Holton; Tamas Revesz
Journal:  Brain       Date:  2004-10-27       Impact factor: 13.501

View more
  37 in total

1.  Cognitive impairment in progressive supranuclear palsy is associated with tau burden.

Authors:  Shunsuke Koga; Adam Parks; Koji Kasanuki; Monica Sanchez-Contreras; Matthew C Baker; Keith A Josephs; J Eric Ahlskog; Ryan J Uitti; Neill Graff-Radford; Jay A van Gerpen; Zbigniew K Wszolek; Rosa Rademakers; Dennis W Dickson
Journal:  Mov Disord       Date:  2017-10-30       Impact factor: 10.338

2.  Cognitive impairment and structural brain damage in multiple system atrophy-parkinsonian variant.

Authors:  Francesca Caso; Elisa Canu; Milica Jecmenica Lukic; Igor N Petrovic; Andrea Fontana; Ivan Nikolic; Vladimir S Kostic; Massimo Filippi; Federica Agosta
Journal:  J Neurol       Date:  2019-09-26       Impact factor: 4.849

3.  Fluorescence and autoradiographic evaluation of tau PET ligand PBB3 to α-synuclein pathology.

Authors:  Shunsuke Koga; Maiko Ono; Naruhiko Sahara; Makoto Higuchi; Dennis W Dickson
Journal:  Mov Disord       Date:  2017-04-25       Impact factor: 10.338

4.  Is multiple system atrophy an infectious disease?

Authors:  Gregor Wenning; John Q Trojanowski; Horacio Kaufmann; Thomas Wisniewski; Walter A Rocca; Phillip A Low
Journal:  Ann Neurol       Date:  2018-01-14       Impact factor: 10.422

5.  A critique of the second consensus criteria for multiple system atrophy.

Authors:  Iva Stankovic; Niall Quinn; Luca Vignatelli; Angelo Antonini; Daniela Berg; Elizabeth Coon; Pietro Cortelli; Alessandra Fanciulli; Joaquim J Ferreira; Roy Freeman; Glenda Halliday; Günter U Höglinger; Valeria Iodice; Horacio Kaufmann; Thomas Klockgether; Vladimir Kostic; Florian Krismer; Anthony Lang; Johannes Levin; Phillip Low; Christopher Mathias; Wassillios G Meissner; Lucy Norcliffe Kaufmann; Jose-Alberto Palma; Jalesh N Panicker; Maria Teresa Pellecchia; Ryuji Sakakibara; Jeremy Schmahmann; Sonja W Scholz; Wolfgang Singer; Maria Stamelou; Eduardo Tolosa; Shoji Tsuji; Klaus Seppi; Werner Poewe; Gregor K Wenning
Journal:  Mov Disord       Date:  2019-04-29       Impact factor: 10.338

6.  Neurodegenerative disease concomitant proteinopathies are prevalent, age-related and APOE4-associated.

Authors:  John L Robinson; Edward B Lee; Sharon X Xie; Lior Rennert; EunRan Suh; Colin Bredenberg; Carrie Caswell; Vivianna M Van Deerlin; Ning Yan; Ahmed Yousef; Howard I Hurtig; Andrew Siderowf; Murray Grossman; Corey T McMillan; Bruce Miller; John E Duda; David J Irwin; David Wolk; Lauren Elman; Leo McCluskey; Alice Chen-Plotkin; Daniel Weintraub; Steven E Arnold; Johannes Brettschneider; Virginia M-Y Lee; John Q Trojanowski
Journal:  Brain       Date:  2018-07-01       Impact factor: 13.501

Review 7.  Synucleinopathies.

Authors:  Elizabeth A Coon; Wolfgang Singer
Journal:  Continuum (Minneap Minn)       Date:  2020-02

8.  TDP-43 pathology in multiple system atrophy: colocalization of TDP-43 and α-synuclein in glial cytoplasmic inclusions.

Authors:  S Koga; W-L Lin; R L Walton; O A Ross; D W Dickson
Journal:  Neuropathol Appl Neurobiol       Date:  2018-05-09       Impact factor: 8.090

9.  Do multiple system atrophy and Parkinson's disease show distinct patterns of volumetric alterations across hippocampal subfields? An exploratory study.

Authors:  Na Wang; Liang Zhang; HuaGuang Yang; XiaoGuang Luo; GuoGuang Fan
Journal:  Eur Radiol       Date:  2019-02-22       Impact factor: 5.315

Review 10.  Diagnosis of multiple system atrophy.

Authors:  Jose-Alberto Palma; Lucy Norcliffe-Kaufmann; Horacio Kaufmann
Journal:  Auton Neurosci       Date:  2017-10-23       Impact factor: 3.145

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.